• Profile
Close
Dr. Alaka Deshpande
Prof. Dr. Alaka Deshpande comments on WHO'... more»Prof. Dr. Alaka Deshpande comments on WHO's latest recommendation for the use of Dolutegravir as the preferred first-line ARV for HIV positive patients. She also mentions that while NACO may follow in this direction, patient counselling and rigid adherence are still key to success. «less
Aug 21, 2019
Dr. Alaka Deshpande details on the signifi... more»Dr. Alaka Deshpande details on the significant damage that undiagnosed thyroid dysfunction can cause to the mother and foetus during pregnancy while outlining key practice points for physicians to adopt early on in order to prevent unfavourable outcomes. «less
May 08, 2019
Dr. Alaka Deshpande covers conditions to b... more»Dr. Alaka Deshpande covers conditions to be ruled out before diagnosing subclinical hypothyroidism (SCH), management of SCH, and the ongoing debate on thyroxine therapy. «less
Mar 30, 2019
Prof. Dr. Alaka Deshpande, a Padmashree aw... more»Prof. Dr. Alaka Deshpande, a Padmashree awardee and a WHO-recognised expert in dealing with HIV/AIDS shares quick notes on HIV diversity and circulating recombinant forms (CRFs). «less
Jan 03, 2019
On this World AIDS Day, we have Prof. Dr. ... more»On this World AIDS Day, we have Prof. Dr. Alaka Deshpande, a Padmashree awardee and a WHO-recognised expert in dealing with HIV/AIDS sharing some important and practical advice that stems from her huge body of work from this area. «less
Dec 01, 2018
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay